Altshuler David's Form 4 filing
Vertex Pharmaceuticals Inc (VRTX) · filed Feb 22, 2023
- Accession no.
- 0001209191-23-011655
- Filed
- Feb 22, 2023
- Trade date
- Feb 17-21, 2023
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 5 non-derivative transactions. Open-market sales total $1.18M. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Altshuler DavidCIK 0001550395 | Officer (EVP, Global Research and CSO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 17, 2023 | Common Stock | FTax withholdingDisposed | −3,750 | $292.85 | −$1,098,187.5 | 44,248 | Direct | |
| Feb 21, 2023 | Common Stock | SSaleDisposed | −36 | $291.01 | −$10,476.36 | 44,212 | Direct | |
| Feb 21, 2023 | Common Stock | SSaleDisposed | −1,223 | $292.76F2,F3 | −$358,045.48 | 42,989 | Direct | |
| Feb 21, 2023 | Common Stock | SSaleDisposed | −1,843 | $294.03F2,F4 | −$541,897.29 | 41,146 | Direct | |
| Feb 21, 2023 | Common Stock | SSaleDisposed | −900 | $294.73F2,F5 | −$265,257 | 40,246 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Dr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Referenced by the price of 3 transactions in Table I.
- F3
Open market sales reported on this line occurred at a weighted average price of $292.76 (range $292.25 to $293.12).
Referenced by the price of 1 transaction in Table I.
- F4
Open market sales reported on this line occurred at a weighted average price of $294.03 (range $293.45 to $294.42).
Referenced by the price of 1 transaction in Table I.
- F5
Open market sales reported on this line occurred at a weighted average price of $294.73 (range $294.47 to $295.37).
Referenced by the price of 1 transaction in Table I.